This Statutory Instrument corrects errors made in S.I. 2020/1647 and is being issued free of charge to all known recipients of that Statutory Instrument.
2022 No. 622
The Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (Amendment) Regulations 2022
Made
Laid before Parliament
Coming into force
The Secretary of State makes these Regulations in exercise of the powers conferred by regulations 5(1) and 11(2) of the Hazardous Substances and Packaging (Legislative Functions and Amendment) (EU Exit) Regulations 2020 (“the Regulations”)1.
By virtue of regulation 9 of the Regulations, the Secretary of State has treated the requirements in regulation 5(2) to (5) of the Regulations as satisfied.
Citation, commencement and extent1
1
These Regulations may be cited as the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (Amendment) Regulations 2022.
2
These Regulations come into force on 1st July 2022.
3
These Regulations extend to England and Wales and Scotland.
Amendment of the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Regulations 20122
1
The Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Regulations 20122 are amended as follows.
2
In Schedule A2—
a
in paragraph 1(a), omit from “other” to the end;
b
in paragraph 1(b), after “EEE” insert “with no expiry date”
;
c
in Table 1, after entry No.96, insert—
97
Bis(2-ethylhexyl) phthalate (DEHP) in ion selective electrodes applied in point of care analysis of ionic substances present in human body fluids and/or in dialysate fluids.
Annex 4, 45
8
21st July 2028
98
Bis(2-ethylhexyl) phthalate (DEHP) in plastic components in magnetic resonance imaging (MRI) detector coils.
Annex 4, 46
8
1st January 2024
99
Bis(2-ethylhexyl) phthalate (DEHP), butyl benzyl phthalate (BBP), and diisobutyl phthalate (DIBP) in spare parts recovered from and used for the repair or refurbishment of medical devices, including in vitro diagnostic medical devices, and their accessories, provided that the reuse takes place in auditable closed-loop business-to-business return systems and that each reuse of parts is notified to the customer.
Annex 4, 47
8
21st July 2028
(This note is not part of the Regulations)